The findings of our study suggest that zinc chelators could contribute to the resolution of myoglobin-induced acute renal injury after crush syndrome by suppressing neutrophil infiltration in ischemia–reperfusion injured muscle. This evidence concerns the gene MB and Crush Syndrome.